Showing results (1-10 of 1,150) with videos related to
Sort By:
Pageof 115
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Diagnosis and management of Waldenstrom's macroglobulinemiaMeletios A Dimopoulos, Robert A Kyle, Athanasios Anagnostopoulos, et al.Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Bortezomib as a treatment option in patients with Waldenström macroglobulinemiaMeletios A Dimopoulos, Christine Chen, Efstathios Kastritis, et al.Expert Review of Clinical Pharmacology|September 7, 2021
Clinical pharmacology and PK/PD translation of the second-generation Bruton's tyrosine kinase inhibitor, zanubrutinibConstantine S Tam, Ying C Ou, Judith Trotman, et al.Blood Cancer Journal|September 11, 2023
Zanubrutinib: past, present, and futureConstantine S Tam, Javier L Muñoz, John F Seymour, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III InnovateTM TrialJudith Trotman, Christian Buske, Alessandra Tedeschi, et al.Blood|January 28, 2012
When a little aspirin may be enoughEfstathios Kastritis, Meletios A DimopoulosCancer Immunology, Immunotherapy : CII|January 19, 2011
Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implicationsEvangelos Terpos, Meletios A DimopoulosHematology. American Society of Hematology. Education Program|January 18, 2011
Renal insufficiency and failureMeletios A Dimopoulos, Evangelos TerposSeminars in Hematology|March 16, 2004
Thalidomide in relapsed/refractory multiple myeloma: pivotal trials conducted outside the United StatesMeletios A Dimopoulos, Athanasios AnagnostopoulosBest Practice & Research. Clinical Haematology|July 20, 2005
Waldenström's macroglobulinemiaMeletios A Dimopoulos, Athanasios AnagnostopoulosPageof 115